MS Virtual 2020: ECTRIMS-ACTRIMS eBook
ECTRIMS MS 2020v1.indd Featuring…. MS Relapses: In the Past? Ofatumumab Steps Closer...
MSVirtual2020: ACTRIMS-ECTRIMS Latest
Eculizumab reduces long-term relapse risk in AQP4+ NMOSD
Long-term efficacy and safety results of eculizumab monotherapy in patients with aquaporin-4 IgG-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) during the PREVENT trial and/or its ongoing open-label extension...
